Our Mission...
is to improve the quality of health service delivery and reduce the burden of disease and disability in the United States and elsewhere by carrying out broadly based research and education activities involving the translation of innovative medical research into practice

PUBLICATIONS

2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004

 

2008

Haddow JE, McClain MR, Lambert-Messerlian G, Palomaki GE, Canick JA, Cleary-Goldman J, Malone FD, Porter TF, Nyberg DA, Bernstein P, D'Alton ME: Variability in thyroid stimulating hormone suppression by human chorionic gonadotropin during early pregnancy. J Clin Endocrinol Metab, 93:3341-3347, 2008.

Haddow JE, Palomaki GE, Canick JA, Knight GJ: Prenatal screening for open neural tube defects and Down’s syndrome. In: Fetal Medicine: Basic Science and Clinical Practice. Rodeck CH, Whittle MJ (eds), Churchill Livingstone: London, pp. 243-264, 2009.

Kavsak PA, Ko DT, Newman AM, Palomaki GE, Lustig V, MacRae AR, Jaffe AS: “Upstream markers” provide for early identification of patients at high risk for myocardial necrosis and adverse outcomes. Clin Chim Acta, 387:133-138, 2008.

Kavsak PA, Ko DT, Newman AM, Lustig V, Palomaki GE, MacRae AR, Jaffe AS: Vascular versus myocardial dysfunction in acute coronary syndrome: Are the adhesion molecules as powerful as NT-proBNP for long-term risk stratification? Clin Biochem, 41:436-439, 2008.

Kavsak PA, Newman AM, Ko DT, Palomaki GE, Lustig V, MacRae AR, Jaffe AS: Is a pattern of increasing biomarker concentrations important for long-term risk stratification in acute coronary syndrome patients presenting early after the onset of symptoms? Clin Chem, 54:747-751, 2008.

Lambert-Messerlian GM, McClain MR, Haddow JE, Palomaki GE, Canick JA, Cleary-Goldman J, Malone FD, Porter TF, Nyberg DA, Bernstein P, D'Alton ME; FaSTER Consortium: First- and second-trimester thyroid hormone reference data in pregnant women: a FaSTER (First- and Second-Trimester Evaluation of Risk for aneuploidy) Research Consortium study. Am J Obstet Gynecol, 199:62.e1-6, 2008.

Lambert-Messerlian GM, Palomaki GE, Canick JA: Inhibin A measurement using an automated assay platform. Prenat Diagn, 28:399-403, 2008.

McClain MR, Lambert-Messerlian G, Haddow JE, Palomaki GE, Canick JA, Cleary-Goldman J, Malone FD, Porter TF, Nyberg DA, Bernstein P, D'Alton ME: FaSTER Research Consortium: Sequential first- and second-trimester TSH, free Thyroxine, and thyroid antibody measurements in women with known hypothyroidism: a FaSTER trial study. Am J Obstet Gynecol, 199:129e1-129.e6, 2008.

McClain MR, Palomaki GE, Piper M, Haddow JE: A Rapid-ACCE review of CYP2C9 and VKORC1 alleles testing to inform warfarin dosing in adults at elevated risk for thrombotic events to avoid serious bleeding. Genet Med, 10:89-98, 2008.

McClain MR, Palomaki GE, Hampel H, Westman JA, Haddow JE: Screen positive rates among six family history screening protocols for breast/ovarian cancer in four cohorts of women. Fam Cancer, 7:341-345, 2008.

Monaghan KG, Feldman GL, Palomaki GE, Spector EB; Ashkenazi Jewish Reproductive Screening Working Group; Molecular Subcommittee of the ACMG Laboratory Quality Assurance Committee: Technical standards and guidelines for reproductive screening in the Ashkenazi Jewish population. Genet Med, 10:57-72, 2008.

Palomaki GE, Neveux LM, Donnenfeld A, Lee JE, McDowell G, Canick JA, Summers A, Lambert-Messerlian G, Kellner LH, Zebelman A, Haddow JE: Quality assessment of routine nuchal translucency measurements: a North American laboratory perspective. Genet Med, 10:131-138, 2008.

Urato AC, Peter I, Canick J, Lambert-Messerlian G, Pulkkinen A, Knight G, Jeong YJ, Johnson KL, Bianchi DW: Smoking in pregnancy is associated with increased total maternal serum cell-free DNA levels. Prenat Diagn, 28:186-190, 2008.